News Home

Where Will Amedisys Inc (AMED) Stock Go Next After It Has Risen 10.25% in a Week?

Monday, October 18, 2021 11:51 AM | InvestorsObserver Analysts
Where Will Amedisys Inc (AMED) Stock Go Next After It Has Risen 10.25% in a Week?

Amedisys Inc (AMED) stock is higher by 10.25% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Sentiment Score - ,bullish
Amedisys Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on AMED!

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With AMED Stock Today?

Amedisys Inc (AMED) stock is lower by -3% while the S&P 500 has gained 0.15% as of 11:49 AM on Monday, Oct 18. AMED is lower by -$4.70 from the previous closing price of $156.79 on volume of 215,756 shares. Over the past year the S&P 500 is higher by 30.67% while AMED is lower by -38.18%. AMED earned $7.45 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 20.41. To screen for more stocks like Amedisys Inc click here.

More About Amedisys Inc

Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, and personal care services. The Home Health Segment provides skilled nurses, therapists, and aids to patient's homes throughout the United States. The Hospice segment operates many centers designed to provide comfort and support for terminally ill patients. The Personal Care Segment provides individuals with assistance in the daily living activities. A majority of the company's revenue is derived from the Home Health segment. Additionally, the Hospice segment accounts for a substantial amount of revenue, while the Personal Care segment makes up for the small remaining revenue. Click Here to get the full Stock Report for Amedisys Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App